Physician profile

Lauren J Halby

Family Medicine · Colorado Springs, CO

NPI 1801848759

$4,073.47

in general payments reported to CMS, 2019-2025

41 companies · $1,040 in 2025

The $1,040 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).

See the full distribution for Family Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,602.17

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $472.15 2019-2025
Amgen INC. $404.16 2019-2025 Repatha, Otezla, Otezla
Novo Nordisk INC $357.46 2019-2025 Ozempic, Rybelsus, Wegovy
Astrazeneca Pharmaceuticals LP $347.37 2019-2025 Farxiga, Breztri, Fasenra
Pfizer INC. $342.98 2023-2025
Lilly USA, LLC $264.71 2019-2024 Mounjaro, Zepbound
Astellas Pharma US INC $210.75 2019-2025 Veozah
Inspire Medical Systems, INC. $194.81 2023-2024 Inspire
Glaxosmithkline, LLC. $191.66 2019-2025 Shingrix, Arexvy, Bexsero
Janssen Pharmaceuticals, INC $136.85 2019
Exact Sciences Corporation $122.66 2023-2025 Cologuard Collection Kit
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $101.87 2019-2020
Sanofi-Aventis U.S. LLC $91.38 2019-2025
Boehringer Ingelheim Pharmaceuticals, INC. $81.55 2019
Jazz Pharmaceuticals INC. $60.55 2025
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Idorsia Pharmaceuticals US INC $55.70 2022-2023 Quviviq
Merck Sharp & Dohme LLC $55.53 2019-2024 Vaxelis, Capvaxive, M-M-R II
Aimmune Therapeutics, INC. $52.47 2024-2025 Zenpep
Novartis Pharmaceuticals Corporation $44.42 2022-2024
Radius Health, INC. $43.21 2019
Amarin Pharma, INC. $39.41 2019
Teva Pharmaceuticals USA, INC. $35.47 2020-2025 Austedo Xr
Cranial Technologies, INC $33.57 2022-2025 Doc Band
Insulet Corporation $29.93 2025 Omnipod
Bioventus LLC $26.17 2025 Durolane
Krystal Biotech INC $26.06 2024 Vyjuvek
Kowa Pharmaceuticals America, INC. $25.30 2019-2023 Livalo, Seglentis
Boston Scientific Corporation $22.99 2024
Otsuka America Pharmaceutical, INC. $22.54 2023 Rexulti, Abilify Maintena
Seqirus USA INC $17.19 2024 Flucelvax, Fluad
Actelion Pharmaceuticals US, INC. $17.14 2025 Opsumit, Uptravi
Ibsa Pharma INC. $16.08 2019
Horizon Therapeutics Plc $15.54 2019
Allergan, INC. $15.52 2020
Dexcom, INC. $15.50 2024 Dexcom G6 Transmitter
Assertio Therapeutics, INC. $15.23 2019
Nestle Healthcare Nutrition INC. $14.69 2023
Mdd US Operations, LLC $14.42 2019
Bayer Healthcare Pharmaceuticals INC. $13.70 2025
Therapeuticsmd, INC. $12.71 2019
Ethicon US, LLC $12.07 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lauren J Halby

$4,073.47

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $1,040 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/263189/lauren-j-halby

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.